FDA Rejects Libido Pill For Women Despite Promising Results

http://media.boston.cbslocal.com/CBSBOS_1103201523235900000AA.mp4 BOSTON (CBS) – “You can’t turn on the TV at night without seeing commercial after commercial after commercial for Viagra or Cialis or testosterone for men,” says Amanda Parrish. “We deserve to have fun too. Why is that men get to have fun in the bedroom and women are not supposed to?” Parrish is not shy when it comes to talking about her sex life or even the lack of it. “It got to where I’d be one of those women who would try to maybe be asleep before he got to bed.” So, this busy working mother of four went to her doctor and received a diagnosis of HSDD or Hypoactive Sexual Desire Disorder. Parrish was quickly enrolled in a clinical trial for Flibanserin, a daily pill that promises to do for women what Viagra did for men. The so-called little pink pill delivered results for Parrish and her husband. “It was not like I became randy 24/7. It’s just simply at the end of a long day, even if I had worked, and even if I had gotten the kids fed, there was a desire there that previously had not been there.” Problem solved, right? Wrong. Flibanserin has now twice been rejected by the FDA. In a study the drug maker found 45% of women reported a meaningful benefit, or increased desire, while taking the drug. That was slightly more than the 35% taking a placebo. The FDA concluded that benefit did not outweigh the side effects, like sleepiness...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health Local News Syndicated Local Cialis Dr. Mallika Marshall Flibanserin Libido pink pill Sex Pill For Women Viagra WBZ TV Source Type: news